ProfileGDS4718 / 207345_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 31% 52% 35% 34% 42% 37% 36% 33% 32% 39% 39% 37% 36% 37% 32% 36% 34% 36% 36% 35% 36% 29% 33% 33% 31% 33% 35% 34% 36% 36% 42% 33% 29% 34% 40% 36% 35% 35% 40% 37% 39% 38% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7760235
GSM549102patient 115, normal, homogenized [OPG study]4.6130131
GSM549104patient 119, normal, homogenized [OPG study]5.6461952
GSM549108patient 138, normal, homogenized [OPG study]4.8005435
GSM549119patient 077, normal, homogenized [OPG study]4.7417334
GSM549133patient 032, cancer, homogenized [OPG study]5.0488242
GSM549139patient 042, cancer, homogenized [OPG study]4.8490237
GSM549099patient 107, normal, homogenized [OPG study]4.8098736
GSM549109patient 139, normal, homogenized [OPG study]4.6915933
GSM549110patient 046, normal, homogenized [OPG study]4.64432
GSM549114patient 063, normal, homogenized [OPG study]4.8781339
GSM549122patient 082, normal, homogenized [OPG study]4.9614539
GSM549134patient 033, cancer, homogenized [OPG study]4.844937
GSM549136patient 036, cancer, homogenized [OPG study]4.7344636
GSM549140patient 044, cancer, homogenized [OPG study]4.8176437
GSM549111patient 047, normal, homogenized [OPG study]4.6048932
GSM549113patient 057, normal, homogenized [OPG study]4.7387436
GSM549132patient 031, cancer, homogenized [OPG study]4.7166534
GSM549137patient 038, cancer, homogenized [OPG study]4.7927336
GSM549142patient 047, cancer, homogenized [OPG study]4.9379136
GSM549100patient 110, normal, homogenized [OPG study]4.8043235
GSM549107patient 135, normal, homogenized [OPG study]4.7604636
GSM549115patient 068, normal, homogenized [OPG study]4.4556229
GSM549116patient 072, normal, homogenized [OPG study]4.6248633
GSM549120patient 078, normal, homogenized [OPG study]4.679833
GSM549131patient 030, cancer, homogenized [OPG study]4.5411431
GSM549118patient 074, normal, homogenized [OPG study]4.6720533
GSM549129patient 027, cancer, homogenized [OPG study]4.7659235
GSM549123patient 088, normal, homogenized [OPG study]4.704834
GSM549124patient 006, cancer, homogenized [OPG study]4.8495436
GSM549126patient 015, cancer, homogenized [OPG study]4.7843536
GSM549128patient 025, cancer, homogenized [OPG study]5.0697942
GSM549103patient 117, normal, homogenized [OPG study]4.7470333
GSM549117patient 073, normal, homogenized [OPG study]4.4971729
GSM549138patient 041, cancer, homogenized [OPG study]4.6929434
GSM549141patient 045, cancer, homogenized [OPG study]4.9085740
GSM549130patient 028, cancer, homogenized [OPG study]4.8049436
GSM549101patient 111, normal, homogenized [OPG study]4.791335
GSM549105patient 128, normal, homogenized [OPG study]4.7770735
GSM549106patient 134, normal, homogenized [OPG study]4.9693240
GSM549112patient 048, normal, homogenized [OPG study]4.8248537
GSM549125patient 011, cancer, homogenized [OPG study]4.9570839
GSM549127patient 024, cancer, homogenized [OPG study]4.8745538
GSM549135patient 035, cancer, homogenized [OPG study]4.8288438